Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Zanganeh Mahkam. Director active across 2 companies, notably Summit Therapeutics Inc.. Aggregated, 13 disclosures have been recorded. Breakdown: 3 buys · 0 sell. Total volume traded: €32.7m. Activity tracked since 8 March 2023. The latest transaction was disclosed on 8 April 2025 (X). Regulator: SEC (Form 4). The full history is openly available.